Walthausen & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Walthausen & Co’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-82,560	Closed	-$3.76M	–	149
2020 Q3	$3.76M	Buy	82,560 +36,250	+78%	+$1.52M	0.78%	59
2020 Q2	$2.09M	Sell	46,310 -6,610	-12%	-$296K	0.42%	83
2020 Q1	$2.04M	Sell	52,920 -560	-1%	-$25.8K	0.44%	86
2019 Q4	$2.48M	Buy	+53,480	New	+$2.32M	0.32%	93

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Walthausen & Co's BEAT Position: Q4 2020 in Review

Walthausen & Co sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 82,560 shares — an estimated $3.76M sold.

Walthausen & Co first reported a position in BEAT in Q4 2019 and held it in 4 quarters. The position peaked at $3.76M in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Walthausen & Co reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
Walthausen & Co sold 82,560 BioTelemetry, Inc. shares in Q4 2020, an estimated $3.76M.
Walthausen & Co first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 4 quarters.
Walthausen & Co's BioTelemetry, Inc. position peaked at $3.76M in Q3 2020.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Walthausen & Co's 13F filing for Q4 2020, filed 12 Feb 2021.